21-deoxycortisol (21-DF) is a steroid of strictly adrenal origin formed by the l l-hydroxylation of 17-hydroxyprogesterone. This metabolic pathway is minor in normal subjects, in whom basal plasma concentrations range from 0·03 to O' 63 nmol/L and from 0'865 to 1·50 nmol/L after adrenocorticotrophic hormone (ACTH; Synacthene Irnmediat, Ciba/Geigy, France). However, this metabolic pathway becomes major in 21-hydroxylase-deficient patients: in those who have the classical form of congenital adrenal hyperplasia (CAH) basal plasma 21-DF levels can attain more than 144 nmol/L. The synthesis of two isomers, E and Z, of the 21-deoxycortisol-3-carboxymethyloxime (CMO) hapten enabled us to prepare the corresponding E and Z immunogens by coupling them to bovine serum albumin (BSA), as well as the corresponding iodinated E and Z 21-DF-3-CMO-histamine tracers. We developed a very sensitive radioimmunoassay for 21-DF in plasma by associating an anti-21-DF-3-CMO-BSA-E isomer antibody to an iodinated 21-DF histamine-Z isomer (standard curve IC 50= 8 pg/tube). This plasma 21-DF radioimmunoassay allowed diagnosis of the classical form of CAH in untreated newborn (basal 21-DF levels greater than 144 nmol/L), as well as the late-onset form (post-ACTH 21-DF levels greater than 11· 54 nmol/L), and also permitted detection of 2 l-hydroxylase-deficient heterozygotes of both forms of CAH among the general population (post-ACTH 21-DF levels between 2·02 and 9·52 nmol/L).
SUMMARY. 21-deoxycortisol (21-DF) is a steroid of strictly adrenal origin formed by the l l-hydroxylation of 17-hydroxyprogesterone. This metabolic pathway is minor in normal subjects, in whom basal plasma concentrations range from 0·03 to O' 63 nmol/L and from 0'865 to 1·50 nmol/L after adrenocorticotrophic hormone (ACTH; Synacthene Irnmediat, Ciba/Geigy, France). However, this metabolic pathway becomes major in 21-hydroxylase-deficient patients: in those who have the classical form of congenital adrenal hyperplasia (CAH) basal plasma 21-DF levels can attain more than 144 nmol/L. The synthesis of two isomers, E and Z, of the 21-deoxycortisol-3-carboxymethyloxime (CMO) hapten enabled us to prepare the corresponding E and Z immunogens by coupling them to bovine serum albumin (BSA), as well as the corresponding iodinated E and Z 21-DF-3-CMO-histamine tracers. We developed a very sensitive radioimmunoassay for 21-DF in plasma by associating an anti-21-DF-3-CMO-BSA-E isomer antibody to an iodinated 21-DF histamine-Z isomer (standard curve IC 50= 8 pg/tube). This plasma 21-DF radioimmunoassay allowed diagnosis of the classical form of CAH in untreated newborn (basal 21-DF levels greater than 144 nmol/L), as well as the late-onset form (post-ACTH 21-DF levels greater than 11· 54 nmol/L), and also permitted detection of 2 l-hydroxylase-deficient heterozygotes of both forms of CAH among the general population (post-ACTH 21-DF levels between 2·02 and 9·52 nmol/L).
Additional key phrases: l Z-hydroxyprogesterone; congenital adrenal hyperplasia; late onset congenital adrenal hyperplasia; heterozygotes 21 -deoxycortisol (21-DF) is a steroid synthesized by ll-hydroxylation of 17-0H progesterone (17-0HP) in the adrenal cortex. This biosynthetic pathway, which is minor in normal subjects, becomes major in patients suffering from congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (Fig. 1 ).1 Loriaux et al.,2 using transcortin in a competitive binding assay, were among the first to report high plasma levels of 21-DF in patients suffering from the classical form of CAH. For many years, a diagnosis of 21-hydroxylase deficiency was established only by measurement of basal and/or post-ACTH plasma 17-0HP levels.t-" This assay unequivocally allows diagnosis of the classical and non-classical forms of CAH (in the latter case, 'late-onset CAH', or 'LOCAH', following ACTH stimulation). However, in most cases, post-ACTH plasma 17-0HP measurement fails to detect the heterozygous form of 21-hydroxylase deficiency. In contrast, 21-DF has proved to be a more sensitive marker than 17-0HP in the study of 21-hydroxylase deficiency, since it permits not only diagnosis of CAH, but also detection of more than 900/0 of heterozygous carriers.t-"
The 21-DF assay which led our group to these results was carried out by radiocompetition assay using tritiated 21-DF as the tracer (SA: 50 Ci/rnmol) and anti-21-DF-3CMO/BSA.7 However, because of the relatively low normal basal and post-ACTH plasma 21-DF levels (< 0·86 nmol/L and < 2·02 nmol/L, respectively)," we felt it was necessary to improve the sensitivity of this assay method, thereby reducing the quantity of plasma necessary for the assay. To accomplish this, we prepared a 125 1 21-DF tracer as well as several new, high-affinity anti-21-DF antibodies.
We describe the analytical characteristics of this new 21-DF plasma assay as well as its application to the clinical exploration of patients presenting with 21-hydroxylase deficiency in either the homozygous or heterozygous state.
MATERIALS AND METHODS
Preparation of the 2l-deoxycortisol-3-carboxymethyl-oxime hapten A solution consisting of 21-DF (100 rng in 10 mL of anhydrous methanol) and 100 000 dpm of tritiated 21-DF (Amersham International PLC, Amersham, UK) was cooled to 4°C and 41 mg of pyrrolidine in 10 mL of methanol added to it. Following agitation, 63 mg of (O-carboxymethyl) hydroxylamine hemi-hydrochloride was added. The mixture was brought to and kept at 50°C for 5 min, then cooled to room temperature. The methanol was evaporated under vacuum and the residue redissolved in 20 mL of distilled water. The aqueous solution was adjusted to pH 2 with HCI and extracted with three 20 mL volumes of ethyl acetate. After extraction of the organic phase with three successive 20 mL volumes of 4% NaOH, the 21-DF-3-CMO was precipitated at pH 2, re-extracted with ethyl acetate and crystallized by concentration. The overall reaction yield was 70%.
The product obtained was a mixture of two geometric isomers: E (55%) and Z (45%). The two isomers were separated after esterification, using an excess of diazomethane, followed by silica column chromatography. Diethylether was used as the eluent. The two methyl esters were isolated as oils: (E)-3CMO 21-DF methyl ester (Rf: 0·32; yield: 36%) and (Z)-3CMO 21-DF methyl ester (Rf: 0'25; yield: 23%). Each ester (43 mg) was solubilized in 2 mL of methanol at O°C and I· 2 mL of IN NaOH was added. The reaction was followed by TLC and was stopped by complete elimination of methanol and water under vacuum. Five millilitres of cold water were added and the mixture extracted twice with diethylether. The aqueous solution was acidified under stirring with a cold 2N HCI solution to pH 2 and extracted twice with 10 mL of ethylacetate. Preparation of 21-DF-3-CMO/BSA immunogens The E and Z isomers of the 21-DF-3-CMO hapten were coupled to bovine serum albumin (BSA) using the mixed anhydride method described by Erlanger et al. 8 Forty milligrams of 21-DF-3-CMO were dissolved in 1 mL pure dioxane to which 20 iLL tri-n-butylamine and 11 iLL isobutyl chloroformate were added. The mixture was agitated under nitrogen for 20 min: 140 rng of BSA were dissolved in 8 mL of a 50/50 (v/v) dioxane/water solution and the pH adjusted to 11. This BSA solution was added to the mixed anhydride mixture. The pH was then adjusted to between 8· 5 and 8· 8 and the coupling solution stirred for 4 h at 4°C. The free steroid was then removed by dialysis overnight against distilled water.
The following day, the immunogen solution was adjusted to pH 4·2 with HCI, then frozen at -20°C for 24 h and allowed to thaw at room temperature. The conjugate precipitated in the form of colourless crystals which were redissolved in a 10% sodium bicarbonate solution. The final solution was again dialyzed for 30 h, then washed with chloroform (2' 5 mL) and lyophilized.
Eighteen moles of 21-DF were covalently bound to one mole of BSA.
Preparation of anti-21-DF antibodies Five New Zealand white rabbits were immunized with immunogen E and another five rabbits with immunogen Z, both prepared as described above. The immunogens (0'5 mg per rabbit), suspended in Freund's complete adjuvant, were administered at 40 subcutaneous sites on the rabbits' shaved backs.? Booster immunizations were carried out each month over a I-year period. Blood was drawn from an ear vein, starting at the third month of immunization.
Preparation of the 21-DF -3-CMO histamine 12SI tracers
Coupling of histamine to 2J-DF-3-CMO The E or Z 21-DF-3-CMO isomer (0,25 mmol) was dissolved in 2· 5 mL of a mixture of dioxane, trion-butylamine, isobutyl chloroformate (5000, 250 and 100 ILL, respectively). After agitating for I h at room temperature under nitrogen, O' 75 mmol of histamine dissolved in 500 ILL of distilled water was added. This mixture was agitated overnight at room temperature.
The following day, after addition of 10 mL of 0·1 M sodium bicarbonate, the 21-DF-3-CMOhistamine was extracted by the successive addition of three 10 mL volumes of dichloromethane. The resulting organic phase was washed with distilled water, dried on anhydrous sodium sulphate and evaporated to dryness. The dry residue was dissolved in a minimal volume of pure dioxane and evaporated to dryness under nitrogen. The product obtained was ready to be labelled with 1251.
Radioactive labelling with 125 1 125 1 was linked to the histamine nucleus by a chloramine T method derived from the Greenwood and Hunter method. 10 The following reagents were added to a 5 mL glass test tube: 10ILL of a I JLIDollmL solution of 21-DF-histarnine in ethanol, 50 ILL of O' 5 M phosphate buffer at pH 7'4, 5 ILL of a 125 1 Na solution (37 MBq; CIS International, Ref. 1 125-S4) and 25 ILL of a I . 8 mg/mL chloramine T solution in phosphate buffer prepared immediately prior to use.
After agitation, the mixture was allowed to react for 2 min. The reaction was then stopped by adding 25 ILL of an aqueous solution of 3' 6 mg/mL of sodium metabisulphite. The reaction mixture was made alkaline by addition of 400 ILL of a O· I M sodium bicarbonate solution. The iodinated steroid was extracted by adding 2 vol of 800 ILL of ethyl acetate. The organic phases were separated, then recombined Ann cu« Biochem 1994: 31 in another tube and evaporated to dryness under nitrogen.
Purification of radiolabe//ed 2J-DF Radiolabelled 21-DF was purified by highpressure liquid chromatography (HPLC), using a Merck Hibar RT 250-10 column containing Lichrosorb SI 60 7 IL as the stationary phase. The previously obtained dry extract was dissolved in 200 ILL of the mobile phase (5OJo methanol in dichloromethane), then injected on to the column.
The flow rate of the mobile phase was I mL/min. After elution, the iodinated steroid was collected in 500 ILL fractions. Five microlitres of each fraction was withdrawn and the radioactivity measured using an automatic -ycounter (Gammamaster, Pharmacia-LKB, Saint-Quentin-en-Yvelines, France). The most radioactive fractions were combined and evaporated to dryness. The dry residue was then redissolved in pure ethanol and kept at -20°C.
Radioimmunoassay
The radioimmunoassay itself was preceded by an extraction step plus a chromatographic step on celite which was purified as previously described.11 Before extraction, each 0'1 mL plasma sample was added to 2000 dpm of tritiated 21-DF (SA: 60 Ci/mmol; Amersham International PLC) and left to stand for 15 min for recovery assay. The steroid extraction was carried out using 10 to 15 mL of a cyclohexane/ethyl acetate mixture 50150 (v/v). The organic extract was separated from the aqueous phase by freezing with dry-ice and acetone, then evaporated to dryness and redissolved in I· 5 mL of pure isooctane. The separation of 21-DF from other steroids (especially 17-0HP and cortisol) was accomplished by partition chromatography on a celite column prepared in 5 mL Kimble pipettes (0'75 g of a mixture of celite plus diethylene glycol 2/1 w/v) packed up to the 3·2mL mark."
The mobile phases consist of mixtures of isooctane and dichloromethane (DCM) of increasing polarity. The following mixtures were successively added to the column: 5 mL of pure isooctane, then 5 mL of isooctane/DCM mixture (83/17 v/v, which eluted the 17-0HP), and finally 7 mL of an isooctane/DCM mixture (30170 v/v, which eluted 21-DF).
The 21-DF fraction was evaporated to dryness, then redissolved in phosphate-gelatin buffer. 11 The radioimmunoassay itself was carried out on this fraction in quadruplicate under the following conditions: 2 x 0'1 mL and 2 x 0·2 mL of chromatographic eluate plus O: I mL of the 21-DF antibody solution (appropriately diluted) plus 0'1 mL of iodinated 21-DF (20 000 dpm) plus phosphate gelatin buffer to 0·7 mL. After mixing, the mixture was left to stand at 37 cC for 30 min, then at 4 CC overnight.
Aliquots of the chromatographic eluates were counted for recovery assay of each sample.
The following morning, 0·1 mL of 'free' plasma (stripped of steroid by charcoal/dextran) was added, followed by 1 mL of the precipitating reagent consisting of polyethylene glycol and sheep anti-rabbit antibody (PR-TSH; CIS International, Gif-sur-Yvette, France) and the tubes centrifuged for 15 min. After decanting the supernatant, the radioactivity of the precipitates was measured using a multiwell counter (Gammamaster, Pharmacia-LKB).
The eight tubes used for establishing the standard curve contained, respectively, 100, 50, 25,12'5,6'25,3'12,1'56 and 0·78 pg of21-DF. The standard curve was calculated using RIACalc software (Pharmacia-LKB) by means of a smooth spline function from the ratio of precipitated radioactivity in each of the tubes to precipitated radioactivity of the zero standard tube (B/Bo). A standard curve obtained with radioiodinelabelled 21-DF is presented in Fig. 2 . Calculation of the concentrations of plasma 21-DF take into account the percentage of tritiated 21-DF recovered as well as the volume of plasma extracted. Plasma cortisol assays were carried out with a Clinical Assays RIA kit (Incstar Corp, Sorin France, Antony, France). 
Healthy subjects
Blood was drawn every 2 or 3 days during a single menstrual cycle from nine healthy women volunteers (no signs of hirsutism, acne, seborrhoea or menstrual irregularities) aged between 20 and 29 years (mean 26' 2 years).
In addition, 66 volunteers consisting of 18 normal adult men, aged 23 to 48 years (mean 28· 5 years), six normal prepubertal children aged 2 to 8 years (mean 6· I years) and 32 women (also without signs of hirsutism, acne, seborrhoea or menstrual irregularities) aged 25 to 40 years (mean 33· 2 years) in either the follicular or luteal phase. These subjects underwent an ACTH stimulation test with an im injection of O·25 mg of Synacthene Imrnediat (Ciba-Geigy France, Rueil Malmaison, France). Basal plasma 21-DF was measured between 0800 hand 0900 h, and a second measurement was made 1 h after ACTH injection.
Finally, blood was drawn for basal plasma 21-DF assay from 15 pregnant women (after 10 to 15 weeks of amenorrhoea) and from 15 women under oestrogen/progesterone treatment.
Five normal women volunteers took 1 mg of dexamethasone by mouth at 2400 h and were sampled the following day at 0800 h.
Late onset CAH patients
The 27 late onset CAH patients, none of whom demonstrated sexual ambiguity at birth, were diagnosed on the basis of abnormally high post-ACTH plasma 17-0HP levels (>32nmoVL).12-16 They consisted of 21 untreated premenopausal women aged 16 to 24 years (mean 25 years), of whom 15 were in the follicular phase and six in the luteal phase, who had developed hirsutism and/or acne and/or seborrhoea during the peri pubertal period, and of six untreated prepubertal children, four girls and two boys, aged 6 to 10 years (mean 7· 2 years) who had precocious pubic hair growth.
CAH patients
This group of 34 consisted of four untreated newborn infants diagnosed as having the classical form of CAH: three girls, all of whom demonstrated sexual ambiguity, and one boy, detected on the basis of salt loss; as well as of 30 adult women who were under hydrocortisone treatment for CAH.
TABLE I. Cross reactivities of anti-Ll-deoxycortisoi antiserum 3005
Cross-reaction (070)
Recovery of tritiated 21-DF
Seventy to eighty per cent of the tritiated 21-DF was recovered after extraction and chromatography.
Blank values
A steroid-stripped plasma sample was assayed in each radioimmunoassay batch. Blank values were very rarely distinguishable from zero levels of 21-DF; in such cases, the plasmas were re-assayed, Specificity l l-deoxycortisol and corticosterone are co-eluted in the same chromatographic fraction as 21-DF. However, the high plasma corticosterone (200 nmollL) and l l-deoxycortisol (14,43 nmol/L) concentrations obtained from steroid-free plasma loaded with corticosterone and ll-deoxycortisol reacted in the 21-DF assay as if they were only 0·088 nmollL of 21-DF for plasma loaded with corticosterone and were undetectable as 21-DF for plasma loaded with ll-deoxycortisol.
21-0H deficiency heterozygotes
Forty-eight healthy untreated heterozygous carriers, 30 with the classical form of CAH and 18 with the late onset form, were detected on the basis of family links to index cases presenting 21-0H deficiency, and by HLA haplotyping, These heterozygotes were subjected to the same ACTH test as described for healthy subjects (above).
RESULTS

Choice of the best antibody
Titres of anti-21-DF antibodies were determined after each booster immunization, using tritiated 21-DF (SA: 50 Ci/mmol). One year after immunization, the titre of each antibody was measured using radioiodine-labelled 21-DF that we synthesized from both the E and Z isomers of the 21-DF-3-CMO hapten. The titres thus obtained, that is, rabbit immunoserum dilutions which bound 50070 of the iodinated tracer, were between O·2 x 10-5 and O·5 x 10-6. Immunosera obtained from both E and Z immunogens were tested against iodinated E and Z tracers. Immunosera 3001, 3002, 3003, 3004 and 3005, obtained by injecting rabbits with E immunogens in association with the 21-DF iodinated Z isomer, gave the most sensitive standard curves.
Sensitivity of the standard curve
With antiserum 3005, the quantities of 21-DF required to yield a BIBo ratio equal to 80%, 50% and 20%, respectively, were 2· 88 fmol, 23 ·08 fmol and 115·44 fmol per tube (Fig. 2) . The least detectable dose was 0·86 fmolltube. The final working dilution of antibody 3005 was 11750000. 
21-deoxycortisol
17-hydroxypregnenolone Cortisone Testosterone l l o-hydroxyprogestercne Pregnenolone Dehydroepiandrosterone Androstenedione
II~-hydroxyandrostenedione
Estradiol 100 0·6 0·01 0·49 0·1 0·08 1·12 4·27 <0·01 <0·01 <0·01 0·04 <0·01 <0·01 <0·01 <0·01 <0·01
Specificity of antiserum 3005
Cross reactions were carried out using the iodinated 21-DF isomer Z, established according to Abraham's method'? (Table 1) .
Reliability of the assay Reproducibility
Intra-and inter-assay coefficients of variation were 7% (n = 15) and 10% (n = 30), respectively.
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Accuracy
The mean recovery of the 21-DF (1,44 nmollL) added to 15 individual plasma samples containing O' 14 to 4· 32 nmollL was 99· 5% (range 95 to 107%). Ten plasma samples with high 21-DF concentrations (2' 59-4' 32 nmol/L) were diluted progressively (2-to 32-fold) with steroid-stripped plasma samples and radioimmunoassayed at each dilution, according to the procedure described above. At all dilutions, the measured values ranged from 94 to 106070 of the expected values.
Plasma 21-DF concentrations in normal subjects
Concentrations measured in samples obtained from nine normal women every 2 to 3 days during the follicular phase of their menstrual cycles (after menstruation) were not significantly different from levels measured during the luteal phase ( Table 2) . A highly significant correlation (P<O'()()()I) was established between basal plasma 21-DF and cortisol plasma values in 103 samples obtained from these nine normal women.
Basal 21-DF levels (nmol/L) in 15 pregnant women and in 15 oestrogen/progesterone-treated women were 0·57 (0'25) and 0'43 (0'20) [mean (SD; standard deviation)], respectively. The basal plasma 21-DF values in these oestrogen-loaded women were significantly higher (P<O·Ol) than those found in untreated women. Postdexamethasone 21-DF plasma levels in the five normal women were undetectable.
Basal 21-DF concentrations in the 25 normal women, 18 normal men and eight normal children were between O' 03 and O' 57 nmol/L and post-ACTH concentrations were between O' 86 and 1· 50 nmol/L ( Table 3 ).
Plasma 21-DF concentrations in patients with 2l-hydroxylase deficiency Basal plasma 21-DF concentrations measured in a group of late onset CAH patients (Table 3) were significantly higher than the basal levels found in all the normal subjects we studied (P<O·OOl). Ninety per cent of these patients had basal 21-DF TABLE 2. Plasma 2J-deoxycortisol concentrations (nmol/L) in nine normal women sampled every 2 to 3 days during a single menstrual cycle levels which were higher than the highest value found among the normal subjects, O' 63 nmol/L.
In 100070 of the cases, post-ACTH 21-DF concentrations in these same 27 late onset CAH patients were higher than the post-ACTH 21-DF values found among normal subjects. In addition, the lowest post-ACTH 21-DF level measured in these late onset CAH patients (11. 54 nmol/L) was much higher than the highest post-ACTH level found in the 51 normal subjects (1' 50 nmol/L).
The 21-DF concentrations measured in the four untreated newborn infants (three girls and one boy) with 21-0H deficiency were 490'6,207'8, 202'0 and 187'6nmol/L, respectively.
In a group of children and adults being treated for CAH, basal 21-DF levels were between 0'28 and 170' 3 nmol/L.
Plasma 21-DF concentrations in heterozygous carriers
Basal 21-DF concentrations measured in 48 heterozygous carriers of both forms of CAH were significantly higher (P<O'Ol) than those found in normal subjects (Table 3) . Forty-eight per cent of these heterozygotes had basal 21-DF levels higher than the upper limit value (0,63 nmol/L) measured in the normal subjects studied.
One hour after ACTH, the plasma 21-DF concentrations of the 30 classical-form CAH heterozygous carriers ranged from 2'02 to 9· 52 nmol/L and in 100% of the cases were higher than the upper limit (1. 50 nmol/L) measured in the 51 normal subjects studied. The 18 late onset CAH heterozygotes had post-ACTH 21-DF levels between 2'16 and 8'22, all above the upper limit of the normal group. has been described, as has the application of this technique to the study of 2l-hydroxylase deficiency. Separation of the E and Z isomers of the 3-CMO-2l-DF hapten allowed us to obtain corresponding E and Z immunogens by BSAcoupling, and then, by histamine coupling followed by iodination, to synthesize the corresponding iodinated E and Z tracers. Among the nine immunosera prepared (5 E and 4 Z) , several E, when associated with the iodinated Z 2l-DF tracer, exhibited 10-fold-superior sensitivity to that obtained with a tritiated tracer. 7 To our knowledge, this procedure has not been used before in the development of a steroid radioimmunoassay. Indeed, after chemical synthesis, 3-CMO steroid hap tens are not usually segregated into their E and Z isomers before being coupled to a carrier. However, such isomeric segregation is not trivial, since it allows the preparation of corresponding antibodies with clearly distinct specificities, as we have previously shown;"
It has also been shown that steroid radioimmunoassays which employ an iodinated tracer in strictly homologous systems sometimes suffer from a lack of sensitivity because there is too great an affinity of the antibody for the corresponding iodinated tracer. Indeed, in such case, the antibody not only recognizes the steroid, but also the carboxymethyloxime bridge at the same time.'?
The introduction of a small modification in the spatial structure of the iodinated tracer (the Z isomer of the iodinated tracer combined with its E immunogen) might explain the great sensitivity of the standard curve obtained with antibody 3005, derived from this association. Such highsensitivity is not insignificant, since this radioimmunoassay may be used in diagnosing 2l-hydroxylase deficiency in newborn infants using small quantities of blood.
The specificity of the antiserum, although higher than that previously published," in our opinion does not justify skipping the extraction and chromatographic purification steps, at least not when 2l-DF levels are low. The celite chromatography system used in the 2l-DF radioimmunoassay described in the present article eliminates interference due to plasma cortisol (Table 1) . Indeed, cortisol is more polar than 2l-DF; consequently it is eluted later.
The reproducibility and accuracy of this new assay were similar to those classically described for most steroid radioimmunoassays. The pretreatment of the celite, as reported before, II eliminated non-specific blank values.
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Using the new assay, normal subjects gave lower 2l-DF values than we have previously reported." This slight but noticeable discrepancy might be related to the higher specificity of our new assay system.
The absence of increased 2l-DF level during the luteal phase compared with levels obtained during the follicular phase in the same adult women is an argument in favour of the strictly adrenal origin of this steroid. This organspecific origin of 2l-DF, in contrast to the dual gonadal and adrenal origins of 17-0HP, is not insignificant in the exploration of 2l-0H deficiency, a defect which is of strictly adrenal origin.
The high correlation between basal plasma 2l-DF and cortisol concentrations in samples taken every 2 to 3 days during the menstrual cycle of nine women is an argument in favour of the influence of endogenous ACTH (and 'stress') on 2l-DF secretion. However, only post-ACTH plasma concentrations were taken into account in order to detect abnormal 2l-DF levels.
The significantly higher plasma 2l-DF levels in oestrogen-treated women and in pregnant women may be explained by the higher cortisol binding globulin-bound 2l-DF levels in these women. However, 2l-DF radioimmunoassay for diagnostic purposes was carried out only in untreated subjects.
Plasma 2l-DF assay permits detection of nonclassical forms of adrenal2l-0H deficiency (late onset CAH),6 while being at least as sensitive as the conventional17-0HP assay. However, as for l7-0HP, the detection of non-classical forms of 2l-0H deficiency requires ACTH stimulation, since the basal plasma 2l-DF level does not allow positive identification of all cases.
In untreated newborn infants with CAH due to 2l-0H deficiency, plasma 2l-DF concentrations were very high, thereby leading to a positive diagnosis of this hereditary disorder. The very high sensitivity of this assay as well as the very high plasma levels of 21-DF encountered in such untreated newborn allow diagnosis using as little as 100 JLL or less of blood.
It was interesting to observe that during therapeutic follow-up of patients with the classical form of CAH, plasma 2l-DF levels were high, normal or low. Although not yet in general use, this steroid assay could constitute another parameter in the therapeutic follow-up for CAH, complementing those which are already used, such as 17-0HP and androgens. 2o -22
Plasma 21-DF concentrations obtained in the CAH obligatory heterozygote CAH population we studied after ACTH injection (1M) were always higher than those measured in our apparently 'normal' population. There was no overlap and these results are close to those we previously reported.Y Based on the results reported both in the present and previous work,5,6 post-ACTH 21-DF assay seems capable of distinguishing 21-0H deficiency heterozygotes from normal subjects, and therefore may be able to detect heterozygous carriers among the general population. Post-ACTH plasma 17-0HP assay demonstrates inferior results in the detection of 21-0H deficiency heterozygotes. Indeed, results reported by numerous authors 23-28 as well as ourselves':" have shown an overlap of from 200/0 to 80% between post-ACTH 17-0HP levels in both normal subjects and heterozygote carriers of 21-0H deficiency, indicating a lesser ability to distinguish heterozygotes from normal subjects.
Considering that the high incidence of carriers of this defect is I in 50,29-32 it is impossible to be sure that the highest concentrations found among the 'general population' do not in fact correspond to carriers. It is possible that the lower limit of 21-DF among heterozygotes may be lower than we found it to be.
In summary, we report the development of a new sensitive technique for the assay of 21-DF in plasma, allowing the determination of the concentrations of this steroid in a very small plasma sample. We report new normal basal and post-ACTH 21-DF values, and new mean and extreme values for this parameter in late onset CAH patients as well as in late onset CAH heterozygotes. We also confirm the usefulness of this assay in the study of 21-0H deficiency in both the homozygous and (especially) heterozygous forms.
